uniQure is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Matthew Craig Kapusta, with a market cap of $1.0B.
Common questions about uniQure
uniQure is scheduled to report earnings for Q1 2026 on May 8, 2026. Analysts estimate revenue of $5.5M.
uniQure has approximately 480 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.